HOME >> BIOLOGY >> NEWS
Receptor could be target for cancer therapy

Tumor cells have evolved a crafty scheme for protecting themselves from the killing power of the host immune system; in part, they disable the immune response.

New studies from a group of Vanderbilt University Medical Center investigators implicate a receptor for prostaglandin E2 (PGE2) in this phenomenon of tumor-induced immune suppression.

The findings, published in the March 1 Journal of Clinical Investigation, suggest that drugs that block the PGE2 receptor, called EP2, might restore the immune system's tumor-killing capacity.

"In two different transplantable tumor models in mice, it looks like the EP2 receptor is a key mediator of the tumor's immunosuppressive action," said Richard M. Breyer, Ph.D., associate professor of Medicine and Pharmacology.

The team of investigators, including Breyer, Dr. David P. Carbone, Ingram Professor of Cancer Research at the Vanderbilt-Ingram Cancer Center, and graduate student Li Yang, injected colon and lung cancer cells into two groups of mice -- normal mice and mice lacking the EP2 receptor (EP2 knockout mice). Tumors were smaller in the EP2 knockout mice, and these mice survived for longer periods of time compared to control mice.

"Not having an EP2 receptor appears to slow cancer growth and improve survivability," Breyer said. The researchers tracked the EP2 receptor effect to a difference in immune system function -- the EP2 knockout mice appeared to mount an effective tumor-killing immune response; the control mice did not.

Breyer's focus on the EP2 receptor stems from his long-standing interest in the biological effects of prostaglandins, a family of locally acting hormones produced by the cyclooxygenase (COX) enzymes. COX enzymes are the targets of aspirin and other non-steroidal anti-inflammatory drugs, which work to relieve pain and inflammation by blocking the production of prostaglandins.

The connection between COX and cancer was made in the early 1990s, Breyer said, when researc
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
5-Mar-2003


Page: 1 2 3

Related biology news :

1. Receptor found that guides nerve cells to their final connecting sites
2. Receptor-dependent protein activation without a receptor
3. Researchers Engineer A Way To Improve T-Cell Receptors
4. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
5. Scientists Discover Function For Type III TGF-Beta Receptor
6. Antiviral From Advanced Viral Research Corp. Inhibits CCR5 Cell Receptor For HIV
7. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
8. Scientists Discover Key Cog In Receptor That Governs Ripening
9. UCSF/Gladstone Finding May Explain HIVS Ability To Infect Cells Lacking The Key Target Of HIV: The CD4 Receptor
10. Receptor May Increase Risk Of Urinary Tract Infections
11. New Findings On Receptor Regulation May Lead To Better Drugs For Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... ... Summit in Nashville, TN, from December 6-9, 2018 at booth #312. AANS/CNS provides ... seamlessly integrates throughout the treatment continuum – from the consultation, to surgical planning, ...
(Date:12/5/2018)... ... December 03, 2018 , ... uBiome, the leader in microbial ... the Division of Gastroenterology and Hepatology at UC San Diego and staff gastroenterologist ... the board of leading scientists and doctors from around the world, Dr. Zarrinpar ...
(Date:12/5/2018)... ... December 04, 2018 , ... Slone Partners, North America’s ... of Michael Mercer at Karius, Inc. as Chief Commercial Officer. Now responsible for ... at Karius' headquarters in Redwood City, California and report to CEO Mickey Kertesz ...
Breaking Biology News(10 mins):
(Date:11/20/2018)... ... ... Each year Forbes receives thousands of nominations for candidates wishing to be selected for ... years of age. The Forbes 30 Under 30 list showcases the top 30 individuals ... Science. , In 2017, Visikol CEO Dr. Michael Johnson was named to the ...
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), Inc. announces it is ... studies, published last week, confirm pose a significant health risk. The two ... that stethoscopes are often improperly or rarely disinfected. In the AJIC November 6 ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon Kleyne, ... Science® in Grants Pass, Oregon believes in the power of talk radio education ... Life Science® sponsors the Power of Water® on talk radio every week with ...
(Date:11/9/2018)... ... November 08, 2018 , ... Superior Controls, ... IT solutions with 140 employees on both the east and west coasts, today ... Pennsylvania Convention Center on November 14 and 15 in Philadelphia. The event is ...
Breaking Biology Technology:
Cached News: